Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.

The outbreak of SARS-CoV-2 disease (COVID-19) is currently, March 2020, affecting more than 100000 people worldwide and, according to the WHO (World Health Organization), a pandemic is shortly expected. The virus infects the lower respiratory tract and causes severe pneumonia and mortality in approximately 10% and 3-5%, respectively, of cases, mainly among the elderly and/or people affected by other diseases. AHCC is an α-glucan-based standardized mushroom extract that has been extensively investigated as an immunostimulant both in animals and/or in humans affected by West Nile virus, influenza virus, avian influenza virus, hepatitis C virus, papillomavirus, herpes virus, hepatitis B virus and HIV by promoting a regulated and protective immune response. Although the efficacy of AHCC has not yet been specifically evaluated with respect to SARS-CoV-2 disease, its action in promoting a protective response to a wide range of viral infections, and the current absence of effective vaccines, could support its use in the prevention of diseases provoked by human pathogenic coronavirus, including COVID-19.

[1]  Perussia.  The Cytokine Profile of Resting and Activated NK Cells , 1996, Methods.

[2]  A. M. Leontovich,et al.  The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.

[3]  M. Shin,et al.  The Effects of AHCC®, a Standardized Extract of Cultured Lentinura edodes Mycelia, on Natural Killer and T Cells in Health and Disease: Reviews on Human and Animal Studies , 2019, Journal of immunology research.

[4]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[5]  S. Perlman,et al.  Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology , 2017, Seminars in Immunopathology.

[6]  K. Block,et al.  Immune System Effects of Echinacea, Ginseng, and Astragalus: A Review , 2003, Integrative cancer therapies.

[7]  E. Gardner,et al.  Short-term supplementation with active hexose correlated compound improves the antibody response to influenza B vaccine. , 2013, Nutrition research.

[8]  Elliot J. Lefkowitz,et al.  Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV) , 2017, Nucleic Acids Res..

[9]  D. Pennington,et al.  Thymic Determinants of γδ T Cell Differentiation. , 2017, Trends in immunology.

[10]  P. Bánovčin,et al.  Respiratory Tract Infections and the Role of Biologically Active Polysaccharides in Their Management and Prevention , 2017, Nutrients.

[11]  G. Chang,et al.  Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice. , 2009, The Journal of nutrition.

[12]  S. Miyazaki,et al.  Effects of AHCC® on Immune and Stress Responses in Healthy Individuals , 2018, Journal of evidence-based integrative medicine.

[13]  R. Olsen,et al.  From Bench to Bedside: Evaluation of AHCC Supplementation to Modulate the Host Immunity to Clear High-Risk Human Papillomavirus Infections , 2019, Front. Oncol..

[14]  B. Ritz,et al.  Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice. , 2009, Nutrition research.

[15]  B. Ritz,et al.  Supplementation with active hexose correlated compound increases the innate immune response of young mice to primary influenza infection. , 2006, The Journal of nutrition.

[16]  Christian Drosten,et al.  Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group , 2013, Journal of Virology.

[17]  S. Wasser.  Medicinal Mushrooms in Human Clinical Studies. Part I. Anticancer, Oncoimmunological, and Immunomodulatory Activities: A Review. , 2017, International journal of medicinal mushrooms.

[18]  Long Jiang Zhang,et al.  Coronavirus Disease 2019 (COVID-19): A Perspective from China , 2020, Radiology.

[19]  J. Peiris,et al.  Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome , 2003, The Lancet.

[20]  M. V. van Zelm,et al.  Studies into the mechanism of measles-associated immune suppression during a measles outbreak in the Netherlands , 2018, Nature Communications.

[21]  Xin Meng,et al.  Antitumor polysaccharides from mushrooms: a review on the structural characteristics, antitumor mechanisms and immunomodulating activities. , 2016, Carbohydrate research.

[22]  J. A. Comer,et al.  A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[23]  Y. Simoni,et al.  Invariant NKT cell development: focus on NOD mice. , 2014, Current opinion in immunology.

[24]  Yunhui Liu,et al.  Potential interventions for novel coronavirus in China: A systematic review , 2020, Journal of medical virology.